Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China.
School of Medicine, Xi'an International University, Xi'an 710077, China.
Biomolecules. 2024 May 4;14(5):554. doi: 10.3390/biom14050554.
Osteoporosis (OP), a prevalent skeletal disorder characterized by compromised bone strength and increased susceptibility to fractures, poses a significant public health concern. This review aims to provide a comprehensive analysis of the current state of research in the field, focusing on the application of proteomic techniques to elucidate diagnostic markers and therapeutic targets for OP. The integration of cutting-edge proteomic technologies has enabled the identification and quantification of proteins associated with bone metabolism, leading to a deeper understanding of the molecular mechanisms underlying OP. In this review, we systematically examine recent advancements in proteomic studies related to OP, emphasizing the identification of potential biomarkers for OP diagnosis and the discovery of novel therapeutic targets. Additionally, we discuss the challenges and future directions in the field, highlighting the potential impact of proteomic research in transforming the landscape of OP diagnosis and treatment.
骨质疏松症(OP)是一种常见的骨骼疾病,其特征是骨强度受损和骨折易感性增加,这是一个重大的公共卫生问题。本综述旨在对该领域的研究现状进行全面分析,重点介绍蛋白质组学技术在阐明 OP 的诊断标志物和治疗靶点方面的应用。将尖端蛋白质组学技术的整合使得能够鉴定和定量与骨代谢相关的蛋白质,从而更深入地了解 OP 的分子机制。在本综述中,我们系统地研究了与 OP 相关的蛋白质组学研究的最新进展,强调了 OP 诊断的潜在生物标志物的鉴定和新治疗靶点的发现。此外,我们还讨论了该领域的挑战和未来方向,强调了蛋白质组学研究在改变 OP 诊断和治疗格局方面的潜在影响。